Identification of new prognostic molecular markers in glioblastoma: a single-center retrospective study.

Oncologist · 2026 · PMC13070693 · PMID 41838417

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

showed a trendP = .054so close (0.05 < p ≤ 0.1)

NOTCH1 substitutions showed a trend towards improved progression-free survival (PFS) (HR = 0.55 [0.30; 1.01], P = .054).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.